Phosphodiesterases (PDEs) may modulate inflammatory pathways, but PDE expression is poorly documented in humans with sepsis. Using quantitative PCR on whole blood leukocytes, we characterized PDE mRNA expression in healthy volunteers (n = 20), healthy volunteers given lipopolysaccharide (LPS; n = 18), and critically ill patients with (n = 20) and without (n = 20) sepsis. PDE4B protein expression was also studied in magneticactivated cell sorting (MACS)-isolated CD15 + neutrophils (from 7 healthy volunteers, 5 patients without and 5 with sepsis). We studied relationships between PDE expression, HLA-DR (mRNA and expression on CD14 + monocytes), tumor necrosis factor (TNF)-a, and interleukin (IL)-10 levels. LPS administration in volunteers was associated with increases in PDE4B and PDE4D and decreases in PDE4A and PDE7A mRNAs. The observed global down-regulation of the HLA-DR complex was correlated with PDE7A. Critically ill patients had lower TNF-a/IL-10 mRNA ratios than the volunteers had and global down-regulation of the HLA-DR complex. Septic patients had persistently lower mRNA levels of PDE7A, PDE4A, and 4B (also at a protein level) and decreasing levels of PDE4D over time. Low PDE4D mRNA levels correlated negatively with HLA-DMA and HLA-DMB. LPS administration and sepsis are, therefore, associated with different PDE mRNA expression patterns. The effect of PDE changes on immune dysfunction and HLA-DR expression requires further investigation.
Introduction
Sepsis remains a leading cause of morbidity and mortality worldwide, despite improved understanding of its pathophysiology during the past few decades [1] . Therapeutic interventions based on the paradigm of an exacerbated inflammatory response in sepsis yielded benefit in some acute animal models but gave disappointing results in humans [2] . In recent years, there has been increasing awareness that immunosuppression may actually be predominant in those patients [3] , as illustrated by decreased membrane or mRNA expression of monocyte HLA-DR [4] . cAMP, whose intracellular levels are tightly regulated in a spatiotemporal manner, may affect immune functions through a variety of mechanisms, including PKA activation and downstream modulation of CREB, IL-10, CIITA, or the NF-kB pathway [5] [6] [7] [8] [9] .
Degradation of cyclic nucleotides is dependent on PDEs, a vast group of ubiquitous enzymes comprising .100 different proteins encoded in 11 distinct gene families (PDE1-11) [10] . In human leukocytes, the PDE4 and PDE7 families (PDE3 to a lesser extent) are the most representative and may affect processes like cell migration [11] , T cell function [8] , apoptosis [12] , or cytokine synthesis (e.g., LPS-induced TNF-a expression [13] ). Up-regulation of certain PDE isoforms has been observed in vitro after LPS stimulation [14, 15] , and pretreatment with PDE inhibitors resulted in modulation of inflammatory processes in several acute animal models of sepsis [16] . Expression of leukocyte PDE has not yet been fully characterized in humans with sepsis or after LPS administration, and PDE inhibition in sepsis has provided conflicting results [17, 18] .
Based on the experimental data suggesting links between cAMP levels (and thus PDE activity) and sepsis-related immune depression [8, [19] [20] [21] , we hypothesized that PDE expression in patients with sepsis, prone to the so-called "postaggressive immune depression" [3] , would be decreased, contrary to in vitro and animal models, in which most PDE isoforms are up-regulated. Because cAMP levels may also modulate HLA-DR expression (in various ways, including PKA-induced phosphorylation of CIITA or CREB activation [22] ), we also studied the relationships between PDE expression and HLA-DR in patients with sepsis and in healthy volunteers administered LPS.
MATERIALS AND METHODS

Subjects
Healthy volunteers given LPS. The study design and methods have been described previously [23] . Briefly, 18 healthy male volunteers were administered i.v., purified LPS (2 ng/kg body weight Escherichia coli O:113, U.S. National Institutes of Health, Bethesda, MD, USA). Blood samples for PDE and HLA-DR mRNA analysis were collected in PAXgene RNA tubes (PreAnalytiX, Qiagen, Hilden, Germany) at baseline (T 0 ), and 2, 4, 8, and 24 (T 2-24 ) h after LPS; in 8 subjects, blood samples were also collected at 72 and 120 h. Samples were kept at 280°C until RNA extraction.
Critically ill patients and healthy volunteers without LPS. Patients with sepsis plus at least one organ dysfunction [24] (n = 20) and patients with no clinical or radiologic signs of sepsis (n = 20) were prospectively included within 24 h of ICU admission (exclusion criteria are listed in the Supplemental Extended Methods online). Healthy volunteers (n = 20) with no infection during the previous 14 d and no coffee or tea consumption for 24 h were recruited from the hospital staff.
The study protocol was approved by the Ethics Committee of CHU Charleroi. Each subject (or close relative) signed written, informed consent. Serum C-reactive protein levels and complete blood cell counts with differentials were measured in each subject. Severity scores (APACHE II, SOFA [25, 26] ) and microbiological data were collected for critically ill patients. In a subset of 8 patients with sepsis, blood was also drawn for kinetics purposes 48 and 96 h after the first blood sample.
Experimental analyses
mRNA extraction and quantitative real-time PCR. In all subjects, total leukocyte RNA was extracted from a 2.5-ml blood sample using a PAXgene RNA Kit (PreAnalytiX) with a DNase I digestion step. Total RNA concentrations and A260/A280 ratios were assessed using spectrophotometry (NanoDrop 2000; Thermo Fisher Scientific, Wilmington, DE, USA). Western blot analysis. Western Blot analysis on PDE4B was performed in CD15 + granulocytes isolated through a MACS sorting procedure (Miltenyi Biotec, Bergisch Gladbach, Germany). Flow cytometry analysis. For LPS-treated healthy volunteers, the expression of HLA-DR on the membrane of circulating monocytes was determined by calculating the percentage of HLA-DR + cells within CD14 + cells within the CD45 + leukocytes, and the HLA-DR mean fluorescence intensity within these CD14 + cells [23] .
Statistical analysis
Normally distributed data were compared with Student's t tests or ANOVAs (for independent or repeated measures). For non-Gaussian distributions, Kruskal-Wallis or Friedman's tests were performed, as appropriate.
Spearman's tests (with Holm's correction for multiple comparisons) were used for proportions and correlations, respectively. P , 0.05 was considered statistically significant. All calculations were performed with SigmaPlot for Windows (version 12.5; Systat Software, Chicago, IL, USA).
Online supplemental material
The Supplemental Extended Methods provide details about the tests and primers used.
Supplemental Table 1 shows correlations between PDE mRNAs and HLA-DR complex in healthy volunteers given LPS. Supplemental Table 2 shows the demographic characteristics of patients with and without sepsis and the healthy volunteers. Supplemental Figure 1 shows PDE mRNA at baseline, 48 h, and 96 h. Supplemental Figure 2 shows correlations between PDE4B and TNF (upper panel) and IL-10 (lower panel) in volunteers and critically ill patients with and without sepsis.
RESULTS AND DISCUSSION
We chose to first study healthy subjects challenged with LPS. Indeed, endotoxin administration has been widely used in animal and human studies as a model of sepsis [2] , but data on leukocyte PDE expression after LPS challenge in humans are limited. Moreover, this model has been used to study PDE expression in acute inflammation settings [13] and, as such, is relevant at least for mechanistic purposes.
In healthy volunteers, i.v. LPS administration was followed by early increases in PDE4B (T 2 and T 4 ) and PDE4D (T 4 ) mRNA expression and decreases in PDE7A and PDE4A mRNA (T 4 and T 8 ), whereas PDE3A and PDE5A mRNA remained unchanged (Fig. 1) . Our results for PDE4B and PDE4D are in accordance with other experiments showing early up-regulation of PDE4B mRNA after LPS stimulation in mouse circulating leukocytes [14] and in human monocytes [15] and up-regulation of PDE4D mRNA and protein in lungs of mice exposed to LPS [20] . By contrast, the decrease we observed in PDE7A mRNA challenges other observations showing up-regulation of PDE7A and B in rat brain after LPS stimulation [27] . Interestingly, at T 24 , expression levels of all PDE mRNAs were similar to baseline conditions and remained stable 72 and 120 h after LPS stimulation in a subset of 8 healthy volunteers (data not shown). Those findings are in accordance with other LPS studies in healthy volunteers in which global gene expression changes in whole blood leukocytes returned to baseline levels at 24 h after LPS infusion [28] .
As expected from previous studies, there was a transient increase in TNF-a and IL-10 mRNA levels (Fig. 2, upper panel) after LPS administration in healthy volunteers (plasma levels have been reported previously [23] ). There were significant, positive correlations between PDE4B mRNA and TNF-a levels (TNF mRNA: r = 0.778, P , 0.001; plasma TNF: r = 0.735, P , 0.001), a finding in accordance with previous in vitro studies in which PDE4B was shown to be important in the TNF-a response after LPS stimulation [13, 14] . LPS administration was also followed by a transient decrease in HLA-DRA (T 2 and T 4 ) and HLA-DMA, HLA-DMB, CD74, and CIITA (T 2 , T 4 , and T 8 ) mRNA expression levels and a transient increase in cathepsin S mRNA (Fig. 3) . This overall decrease was also found at the protein level on
CD14
+ monocytes in a simultaneous FACS analysis (results reported earlier [23] ). This decrease is in accordance with a previous study on circulating monocytes in healthy volunteers administered LPS [29] , whereas, in vitro, LPS-stimulated monocytes exhibited increased HLA-DR surface expression [30] ; those discrepancies may be related to different cytokine environments in these 2 different settings [30] . The transcription factor CREB has been shown to regulate MHC class II expression through the master regulator CIITA [31] ; moreover, in human B lymphocytes, increases in cAMP levels enhanced HLA-DR expression [32] . Therefore, we also studied cAMP-PDE (mainly PDE4 and PDE7 families) expression in relation to the HLA-DR mRNA complex. When considering the entire 24-h study period, PDE4A and PDE7A mRNA levels (both decreased after LPS) correlated with the mRNA expression of the HLA-DR complex (HLA-DRA, DMA, DMB, CD74, and CIITA) and PDE7A levels further correlated with surface HLA-DR (mean fluorescence intensity and percentage of DR + cells) in a FACS analysis on CD14 + monocytes (Supplemental Table 1 ). However, the observational design of our study precludes any causal inference, and our results can only be considered as hypothesis generating.
We next studied the same panel of genes in critically ill patients (septic and nonseptic) in comparison with healthy volunteers. Indeed, the ability of the LPS model to correctly mimic the septic response in humans has been questioned because therapeutic interventions based on that model have generally failed to improve outcomes in patients with sepsis [2] . We, therefore, also compared PDE expression after an LPS challenge to that observed in patients with sepsis and those without sepsis, i.e., patients with inflammatory processes related to noninfectious conditions. Use of this latter group as a second control was relevant because some studies have reported significant differences (e.g., metabolomic) between critically ill, nonseptic and septic patients [33] , whereas other studies have shown considerable overlap in inflammatory responses between critically ill, nonseptic patients (especially after trauma) and subjects administered LPS [34] . The demographic characteristics of study subjects and primary diagnosis (for nonseptic patients) are given in Supplemental Table 2 . Baseline C-reactive protein levels were higher in critically ill patients compared with healthy volunteers, and severity scores (APACHE II and SOFA) were higher in septic than in nonseptic patients. Patients with sepsis most commonly had pneumonia (60%) or intra-abdominal (20%) infections; 4 died in the ICU (20.0%). In 8 patients (40%), infection was related to gram-negative bacteria.
Compared with healthy volunteers, PDE4A, 4B, and 7A mRNA levels were significantly lower in patients with sepsis (Fig. 4) and were even lower in patients with positive blood cultures (gram-positive or gram-negative, n = 8) than in those with negative blood cultures (n = 12) (data not shown). PDE4B mRNA (Fig. 4) and protein expression (Fig. 5) were less in patients with, than in those without, sepsis. Moreover, in a subset of 8 patients with sepsis still alive and in the ICU, the reduced expression of PDE 4A, 4B, and 7A mRNA persisted at 48 and 96 h after the first blood sample following ICU admission, whereas PDE4D levels were decreased at 96 h (Supplemental Fig. 1) .
Levels of TNF-a mRNA were lower in septic patients than they were in healthy volunteers (P = 0.008; Fig. 2, lower panel) , and when considering the entire study cohort, there was a significant correlation between PDE4B and TNF-a mRNAs (r = 0.5, P , 0.001) (Supplemental Fig. 2, upper panel) ; this correlation, already established from previous in vitro experiments [14] , was thus also found in humans, not only after LPS administration but also in other inflammatory settings. There was also a weak, but significant, negative correlation between IL-10 and PDE4B mRNAs (r = 20.38, P = 0.006; Supplemental Fig. 2, lower panel) , in accordance with previously described, reciprocal, inhibitory mechanisms between cAMP-PDE4 and IL-10. In human monocytes, PDE4B gene transcription is down-regulated by IL-10 [15] , and, reciprocally, cAMP may enhance IL-10 gene transcription [35] . Because IL-10 mRNA expression was greater in patients with sepsis (compared with nonseptic patients and healthy volunteers; P , 0.001; Fig. 2, lower panel) , we observed significant decreases in the TNF-a to IL-10 mRNA ratio, a marker for depressed immune status [36] (P , 0.001, data not shown), in those patients. This was also reflected by significantly lower levels of HLA-DRA, -DMA, -DMB, CD74, and CIITA mRNA in septic and nonseptic patients compared with healthy volunteers, whereas cathepsin S was only decreased in septic patients (Fig. 6) .
In a kinetics study on a subset of 8 septic patients, there were significant increases in HLA-DMA mRNA levels between d 1 (first blood sample in the ICU) and d 5 (blood sample 96 h after the first sample) (P = 0.003) and a trend toward an increase in HLA-DRA levels (P = 0.05) (data not shown). Interestingly, IL-10 mRNA levels decreased during the same period (P = 0.003) in the same patient subset. Because IL-10 has been shown to down-regulate HLA-DR expression by inducing the ubiquitin ligase membrane-associated RING-CH (and thus promoting the internalization of the MHC II complex [37] ), we may hypothesize that the decrease in IL-10 favored reexpression of surface HLA-DR. We can also hypothesize that, in septic patients, persistently decreased levels of PDE4A, 4B, and 7A (all cAMP-hydrolyzing PDEs), along with decreasing levels of PDE4D mRNA over time may promote increases in intracellular cAMP concentrations and, thus, also favor HLA-DR expression. Indeed, we observed negative correlations between PDE4D mRNA and HLA-DMA and -DMB (r = 0.75 and 0.76, respectively, P , 0.05). However, this hypothesis remains speculative at this time.
Our study has several limitations. First, we restricted our analyses to only a subset of the most representative PDEs for leukocytes. In leukocytes, the PDE4 family is the most abundant, especially PDE4B [10] . Previous studies have reported an important role for cAMP and PDE4 in TNF-a expression after LPS stimulation [6] , neutrophil recruitment [11, 21] , and apoptosis [12] or T cell function [8] . Inhibition of PDE4 expression has been shown to exert anti-inflammatory actions, in part through cAMP-related PKA stimulation, suppressing the expression of TNF-a (targeting of NF-kB complex members through AKAP [e.g., AKAP95] or through TNF-associated factor 6 inhibition) but also enhancing IL-10 gene transcription (via PKA-dependent CREB phosphorylation) [6, 35, 38, 39] . Although functional differences between PDE4 isoforms may be difficult to uncover, some studies suggest nonredundant functions, notably in neutrophils [11] . The PDE7A family is mostly involved in aspects of B and T lymphocyte function [8] , and TCR/CD28 costimulated cells up-regulate PDE7 levels; however, the functional roles of PDE7 in T cells are controversial [10] . The PDE3 family has the particularity of being cGMP inhibited and is, therefore, one of the players in the crosstalk between cAMP and cGMP [10] . Second, analyses were performed only on whole blood WBCs, using an approach that enabled immediate whole blood-derived leukocyte RNA stabilization [4] . Although that method prevented further leukocyte activation and risks of artifactual mRNA changes, no distinction between leukocyte subsets could be made. However, preliminary data on PDE expression in MACS-isolated monocytes and neutrophils from patients with sepsis show similar results (data not published). Third, in septic patients, the interval between the initial infectious insult (often several days before the hospital admission) and the first blood draw in the ICU was difficult to determine but probably varied among patients. Fourth, PDE expression was only assessed based on mRNA changes, except for neutrophil PDE4B, for which protein expression was also studied because of its abundance and importance in modulating several aspects of immune cell function. However, transition from PDE mRNA changes to protein activity and finally to cyclic nucleotide levels may not be so straightforward. As an example, alterations in adenylyl cyclase signaling during sepsis may also modify cAMP generation [40] .
In conclusion, we document significant and divergent patterns of PDE mRNA expression in volunteers challenged with LPS and in critically ill patients. Those discrepancies may reflect the heterogeneous nature and intensity of inflammatory responses in those groups and highlight the limitations of the LPS model to mimic the septic response, at least regarding PDE expression. LPS infusion resulted in transient up-regulation of certain isoforms, as in previous in vitro experiments, but, in contrast, critically ill patients had decreased PDE mRNA expression. In patients with sepsis who exhibited features of immune depression, inverse correlations between HLA-DR expression and some cAMP-PDE may be linked to experimental data showing cAMP-related HLA-DR modulation. Whether relationships between PDE4 members and HLA-DR components may be of clinical relevance is currently under investigation. 
